Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Sensus Healthcare GAAP EPS of -$0.06 beats by $0.04, revenue of $6.9M beats by $0.59M (SeekingAlpha) +++ SENSUS HEALTHCARE Aktie +3,01%

SENSUS HEALTHCARE Aktie

 >SENSUS HEALTH Aktienkurs 
3.08 EUR    (Tradegate)
Ask: 3.16 EUR / 1257 Stück
Bid: 3 EUR / 1339 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
Aktie über LYNX handeln
>SENSUS HEALTH Performance
1 Woche: +12,0%
1 Monat: +2,7%
3 Monate: -32,3%
6 Monate: -17,6%
1 Jahr: -50,7%
laufendes Jahr: -55,5%
>SENSUS HEALTHCARE Aktie
Name:  SENSUS HEALTHCARE DL-,01
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US81728J1097 / A2JPJ1
Symbol/ Ticker:  5TX (Frankfurt) / SRTS (NASDAQ)
Kürzel:  FRA:5TX, ETR:5TX, 5TX:GR, NASDAQ:SRTS
Index:  -
Webseite:  https://www.sensushealthc..
Profil:  Sensus Healthcare Inc. is a publicly traded compan..
>Volltext..
Marktkapitalisierung:  52.68 Mio. EUR
Unternehmenswert:  34.41 Mio. EUR
Umsatz:  32.62 Mio. EUR
EBITDA:  -0.72 Mio. EUR
Nettogewinn:  -0.74 Mio. EUR
Gewinn je Aktie:  -0.04 EUR
Schulden:  0.52 Mio. EUR
Liquide Mittel:  19.24 Mio. EUR
Operativer Cashflow:  3.1 Mio. EUR
Bargeldquote:  3.46
Umsatzwachstum:  -6.07%
Gewinnwachstum:  -111.6%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  SENSUS HEALTHCARE, SENSUS HEALTH
Letzte Datenerhebung:  06.11.25
>Kennzahlen
Aktien/ Unternehmen:
Aktien: 16.44 Mio. St.
Frei handelbar: 90.57%
Rückkaufquote: 0.41%
Mitarbeiter: 54
Umsatz/Mitarb.: 0.67 Mio. EUR
Analysten:
Analystenrating: Strong buy
Kursziel: 114.55%
Bewertung:
KGV: -
KGV lG: -
KUV: 1.42
KBV: 1.12
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: 52.19%
Gewinnmarge: -2.26%
Operative Marge: -3.64%
Managementeffizenz:
Gesamtkaprendite: -1.45%
Eigenkaprendite: -1.62%
>Peer Group

Es sind 597 Aktien bekannt.
 
06.11.25 - 23:48
Sensus Healthcare übertrifft Umsatzprognose für Q3 2025 – Aktie legt nachbörslich zu (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
06.11.25 - 22:39
Sensus Healthcare GAAP EPS of -$0.06 beats by $0.04, revenue of $6.9M beats by $0.59M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
31.10.25 - 13:03
Sensus Healthcare Announces the Passing of Director Bill McCall (Business Wire)
 
BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the passing of longtime friend of the Company and current Director William “Bill” McCall. Bill's involvement with Sensus dates to 2009, when he played a key role in transforming the company from concept to reality. He led the Company's initial capital raise in 2010 while serving as CEO of Anderson Strudwick, a boutique investment banking firm. He joined the Sensus Healthcare Board of Directors in 2015, providing valued counsel, leadership and insight throughout his tenure. “It is with a heavy heart that we announce the passing of Bill McCall. He was far more than a Director. Bill was a dear friend and one of the very first people who believed in me and in what Sensus could become,” said Joe Sardano, Chairman and Chief Executive Officer of S...
30.10.25 - 00:45
Sensus Healthcare, Inc. (SRTS) Stock Moves -1.83%: What You Should Know (Zacks)
 
Sensus Healthcare, Inc. (SRTS) concluded the recent trading session at $3.21, signifying a -1.83% move from its prior day's close....
24.10.25 - 01:45
Sensus Healthcare, Inc. (SRTS) Outpaces Stock Market Gains: What You Should Know (Zacks)
 
In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $3.29, marking a +2.17% move from the previous day....
23.10.25 - 14:03
Sensus Healthcare to Report Third Quarter 2025 Financial Results and Hold Business Update Conference Call on November 6 (Business Wire)
 
BOCA RATON, Fla.--(BUSINESS WIRE)--$SRTS--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological skin conditions, announces the company will report financial results for the third quarter of 2025 on Thursday, November 6, 2025. Management will hold a conference call beginning at 4:30 p.m. Eastern time to review the results, provide a business update and answer questions. Participants are encouraged to pre-register for the conference call using this link to receive a unique dial-in number to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those unable to pre-register can access the conference call by dialing 844-481-2811 (U.S. and Canada Toll Free) or 412-317-0676 (International). Please ask the operator to be connected to the Sensus Healthcare conference call. The call will be webcast live and can b...
17.10.25 - 01:45
Sensus Healthcare, Inc. (SRTS) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
 
Sensus Healthcare, Inc. (SRTS) closed the most recent trading day at $3.31, moving 4.06% from the previous trading session....
09.10.25 - 01:45
Sensus Healthcare, Inc. (SRTS) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
 
The latest trading day saw Sensus Healthcare, Inc. (SRTS) settling at $3.45, representing a -2.82% change from its previous close....
30.09.25 - 01:45
Sensus Healthcare, Inc. (SRTS) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
 
Sensus Healthcare, Inc. (SRTS) concluded the recent trading session at $3.17, signifying a +2.26% move from its prior day's close....
23.09.25 - 01:45
Sensus Healthcare, Inc. (SRTS) Outperforms Broader Market: What You Need to Know (Zacks)
 
The latest trading day saw Sensus Healthcare, Inc. (SRTS) settling at $3.15, representing a +1.29% change from its previous close....
18.09.25 - 16:03
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS (PR Newswire)
 
NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
13.09.25 - 16:03
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS (PR Newswire)
 
NEW YORK, Sept. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
08.09.25 - 21:03
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS (PR Newswire)
 
NEW YORK, Sept. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
27.08.25 - 16:01
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS (PR Newswire)
 
NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
22.08.25 - 16:03
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sensus Healthcare, Inc. - SRTS (PR Newswire)
 
NEW YORK, Aug. 22, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sensus Healthcare, Inc. ("Sensus" or the "Company") (NASDAQ: SRTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The......
21.08.25 - 16:45
Is Sensus Healthcare (SRTS) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
 
According to the average brokerage recommendation (ABR), one should invest in Sensus Healthcare (SRTS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?...
14.08.25 - 21:01
Insiderhandel: PRESIDENT AND GENERAL COUNSEL kauft Aktien von Sensus Healthcare im Wert von 3370 USD (Insiderkauf)
 
Sardano, Michael - Vorstand - Tag der Transaktion: 2025-08-13...
08.08.25 - 20:48
Sensus Healthcare outlines global expansion and regulatory milestones amid reimbursement uncertainty (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
07.08.25 - 22:36
Sensus Healthcare GAAP EPS of -$0.06 misses by $0.09, revenue of $7.3M misses by $2M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.07.25 - 01:45
Sensus Healthcare, Inc. (SRTS) Stock Drops Despite Market Gains: Important Facts to Note (Zacks)
 
In the most recent trading session, Sensus Healthcare, Inc. (SRTS) closed at $5.51, indicating a -2.48% shift from the previous trading day....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Bildung scheint mir das einzige Ziel, das des Bestrebens, Wahrheit der einzige Reichtum, der des Besitzes würdig ist. - Heinrich von Kleist
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!